Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk 'Golden Years' type 1 diabetes cohort

Diabetes Research and Clinical Practice

Volumn 91, Issue 3, 2011, Pages

  Prior, Sarah L ^a   Jones, Danielle A ^a   Gill, Geoffrey V ^b   Bain, Steve C ^a   Stephens, Jeffrey W ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adiponectin; Coronary heart disease; Gene variant; Obesity; Type 1 diabetes

Indexed keywords

ADIPONECTIN; ALANINE; ANTIOXIDANT; CYSTEINE; GLYCINE; INSULIN; TRIACYLGLYCEROL;

AGED; ALLELE; ARTICLE; DIABETIC PATIENT; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; HUMANS; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 79952362145     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.12.007     Document Type: Article

References (20)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83.
2. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360(9326):57-58.
3. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23(1):85-89.
4. Frystyk J., Tarnow L., Hansen T.K., Parving H.H., Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005, 48(9):1911-1918.
5. Prior SL, Tang TS, Gill GV, Bain SC, Stephens JW. Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk " Golden Years" type 1 diabetes mellitus cohort. Metabolism 2010;[February 24]:in press.
6. Saraheimo M., Forsblom C., Fagerudd J., Teppo A.M., Pettersson-Fernholm K., Frystyk J., et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005, 28(6):1410-1414.
7. Vionnet N., Hani E.H., Dupont S., Gallina S., Francke S., Dotte S., et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67(6):1470-1480.
8. Francke S., Manraj M., Lacquemant C., Lecoeur C., Lepretre F., Passa P., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001, 10(24):2751-2765.
9. Chiodini B.D., Lewis C.M. Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler Thromb Vasc Biol 2003, 23(10):1863-1868.
10. Gong M., Long J., Liu Q., Deng H.C. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010, 325(1-2):78-83.
11. Gu H.F. Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms. Biomark Insights 2009, 4:123-133.
12. Hegener H.H., Lee I.M., Cook N.R., Ridker P.M., Zee R.Y. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem 2006, 52(11):2021-2027.
13. Gable D.R., Matin J., Whittall R., Cakmak H., Li K.W., Cooper J., et al. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet 2007, 71(Pt 4):453-466.
14. Prior S.L., Gable D.R., Cooper J.A., Bain S.C., Hurel S.J., Humphries S.E., et al. Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. Eur Heart J 2009, 30(10):1263-1269.
15. Goyenechea E., Collins L.J., Parra D., Abete I., Crujeiras A.B., O'Dell S.D., et al. The -11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm Metab Res 2009, 41(1):55-61.
16. Bain S.C., Gill G.V., Dyer P.H., Jones A.F., Murphy M., Jones K.E., et al. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 2003, 20(10):808-811.
17. Sampson M.J., Gopaul N., Davies I.R., Hughes D.A., Carrier M.J. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 2002, 25(3):537-541.
18. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1(1):43-46.
19. Jorsal A., Tarnow L., Frystyk J., Lajer M., Flyvbjerg A., Parving H.H., et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 2008, 74(5):649-654.
20. Prior S.L., Javid J., Gill G.V., Bain S.C., Stephens J.W. The adiponectin rs17300539 G>A variant and nephropathy risk. Kidney Int 2008, 74(10):1361.